Register
Register
Register

Thursday, 22 May 2025 | 16:10 - 16:20

Identifying a novel class of shared tumor antigens through an advanced neoantigen discovery pipeline - Gitta Boons, MyNEO Therapeutics

Format:In-person

The talk will cover the neoantigen discovery pipeline of myNEO Therapeutics and its role in identifying a novel and unique class of shared antigen targets derived from the dark genome. These targets are now being investigated in myNEO’s first clinical program, CAMYO-01.

1 speaker